Treatment
Insulin clinical trials
We’re tracking 353 recruiting studies that include Insulin, each written for real people, not researchers, below.
Recruiting studies
- NCT05206877RecruitingPhase 1
Topical insulin eyedrops for glaucoma-related eye nerve damage
This Phase 1 study tests an insulin-based eye treatment to see if it’s safe and potentially helpful for people with glaucoma-related optic nerve damage. If you may be eligible, you’ll have a close eye exam and repeated vision testing, mainly focused on one study eye.
Palo Alto, CaliforniaAges 18 years+ - NCT07076199RecruitingPhase 3
Weekly vs daily insulin for type 1 diabetes
This study tests a new once-weekly insulin (icodec) against a standard daily insulin (glargine), both taken with mealtime insulin. It aims to see which works better to control blood sugar in adults with type 1 diabetes.
Cullman, AlabamaAges 18 years+ - NCT07112339RecruitingPhase 4
Weekly insulin vs daily insulins for type 2 diabetes
This study tests a new once-weekly insulin shot (icodec) compared to daily long-acting insulins for people with type 2 diabetes whose blood sugar is not well controlled on their current non-insulin medications.
Calgary, AlbertaAges 18 years+ - NCT03463564RecruitingPhase 4
Insulin pump versus insulin shots for type 1 diabetes control
This study compares an insulin pump to insulin shots to see which better improves blood sugar control and reduces swings in people with type 1 diabetes. You may be included if your diabetes is not well controlled despite education and you’ve had low blood sugar episodes.
NaplesAges 18–30 - NCT06216665Recruiting
Pulse hormone effects on insulin
This trial is only for people who completed a previous study called Motivate and had their final insulin test. It tests how giving hormones in pulses affects how your body uses insulin.
Baton Rouge, LouisianaAges 50–75 - NCT06280703RecruitingPhase 1
Study of LY3938577 for type 1 diabetes
This study tests an investigational drug called LY3938577 in healthy people and people with type 1 diabetes. It looks at how the drug affects the body and whether it might help control blood sugar.
NeussAges 18–64 - NCT06592261RecruitingPhase 1
Insulin suppression test for weight groups
This study tests a new way to measure how the body handles insulin in people with different body weights. It may help researchers understand insulin resistance better.
New York, New YorkAges 18–65 - NCT06966427Recruiting
Using a dosing app for insulin management
This trial studies a smartphone system that helps people with diabetes decide how much insulin to take. It is for people who use insulin injections or are starting basal insulin, and it uses a continuous glucose monitor to guide dosing.
Petah TikvaAges 6–75 - NCT07171684Recruiting
Insulin Dosing for Blood Sugar Control in Pregnancy
This study compares giving one daily dose of insulin versus multiple doses to see which works better for controlling blood sugar in pregnant women with diabetes. It might help you if you need insulin during pregnancy and want to find a simpler treatment plan.
New Brunswick, New JerseyAges 18–50 - NCT07265323Recruiting
Testing insulin effects on brain function
This study looks at how giving insulin in a way that mimics the body's natural release can affect thinking and memory. It may help understand how insulin relates to brain health.
Baton Rouge, LouisianaAges 18 years+ - NCT07780513Recruiting
Genetics of muscle insulin resistance study
This study looks at how genes affect the way muscles use sugar, which can help understand insulin resistance. Participants will have tests and procedures, including a glucose drink test and a muscle biopsy, to see how their bodies handle sugar.
San Antonio, TexasAges 18–75 - NCT07516509Recruiting
How muscle cells respond to blood sugar in different body types
This research study examines how muscle cells handle blood sugar differently depending on whether someone is lean or has obesity, and whether their body resists insulin. Researchers will take small muscle samples to understand the genetic differences, which may help develop better treatments for insulin resistance and metabolic health.
Orlando, FloridaAges 30–65 - NCT03932162RecruitingEarly Phase 1
Skin study that checks gene changes in young and older adults
This early-stage study looks at how your skin’s genes respond after a controlled skin procedure. It may help researchers understand differences in skin biology between younger and older adults.
Fairborn, OhioAges 21 years+ - NCT07109245RecruitingPhase 4
Do antipsychotics block insulin action in the brain?
This study tests whether a single dose of a common antipsychotic medication affects how the brain responds to insulin, which could help explain weight gain and metabolic side effects. Healthy young adults will receive either the antipsychotic or a placebo, then have their brain activity measured with an MRI.
Toronto, OntarioAges 18–35 - NCT07224893RecruitingPhase 4
Once vs Twice Daily Insulin in Pregnant Diabetes
This trial compares taking insulin glargine once a day versus twice a day for pregnant women with type 2 diabetes. It aims to find which schedule helps manage blood sugar better during pregnancy.
Norfolk, VirginiaAges 18 years+ - NCT07746206RecruitingEarly Phase 1
Insulin vs hyaluronic acid gel for advanced gum disease
This study compares two treatments applied directly to the gums to see which one better helps severe gum disease (periodontitis) heal. If you have advanced gum disease and haven't had treatment recently, you may be able to join.
CairoAges Any age - NCT06925334Enrolling by invitationPhase 4
Comparing a new insulin combo with premixed insulin for type 2 diabetes
This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.
Beijing, Beijing MunicipalityAges 18–75 - NCT07732777Recruiting
AI-assisted insulin pump study for type 1 diabetes
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
Nanjing, JiangsuAges 14–65 - NCT06880835Recruiting
Inhaled insulin vs injected insulin for exercise blood sugar drops in type 1 diabetes
This trial tests whether a new inhaled insulin (Technosphere) causes fewer low blood sugar episodes during exercise compared to standard injected insulin in people with type 1 diabetes who use an automated insulin pump. It may help you avoid hypoglycemia while staying active.
Louisville, KentuckyAges 18–65 - NCT04883515Recruiting
Glutamine drink for insulin resistance and bowel symptoms
This trial studies whether taking an oral glutamine supplement can improve insulin resistance and reduce bowel-related problems in people with obesity and irritable bowel syndrome. It may help your blood sugar regulation and digestive comfort if you meet the criteria.
RouenAges 18–65 - NCT06883344Recruiting
Automated insulin for managing blood sugar during labor
This study tests if an automated insulin delivery system can help manage blood sugar levels during labor and delivery in pregnant women with type 1 diabetes. If successful, it could make the process safer and easier.
Los Angeles, CaliforniaAges 18–55 - NCT05010356Recruiting
Testing insulin sensitivity after breast cancer treatment
This study looks at how well your body uses insulin (a hormone that helps move sugar from the blood into cells) after breast cancer treatment. It may help researchers understand whether insulin sensitivity changes after chemotherapy and could guide future health monitoring.
Copenhagen, DKAges 20–45 - NCT05065372RecruitingPhase 1
Metformin test with automated insulin in teens with type 1
This Phase 1 study tests how adding metformin affects blood flow in the kidneys, insulin sensitivity, and overall heart/metabolic health in young people with type 1 diabetes. It may help researchers understand whether this combo is safe and beneficial alongside automated or pump/shot insulin care.
Aurora, ColoradoAges 12–25 - NCT05233722Recruiting
Study of how mTOR affects insulin sensitivity in healthy men
This study looks at whether a body pathway called mTOR helps control how your body handles insulin and blood sugar. It’s done in healthy men to understand insulin sensitivity before testing approaches in people with health problems later.
CopenhagenAges 22–35
What Insulin is being studied for
Conditions with recruiting Insulin studies.
Common questions
- Are there clinical trials studying Insulin?
- Yes. Clin2 currently lists 353 recruiting studies that include Insulin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Insulin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Insulin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Insulin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.